Related references
Note: Only part of the references are listed.Clonal Hematopoiesis-Driver DNMT3A Mutations Alter Immune Cells in Heart Failure
Wesley Tyler Abplanalp et al.
CIRCULATION RESEARCH (2021)
Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations
Birgit Assmus et al.
EUROPEAN HEART JOURNAL (2021)
Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction
Domingo A. Pascual-Figal et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis
Trevor P. Fidler et al.
NATURE (2021)
Full spectrum of clonal haematopoiesis-driver mutations in chronic heart failure and their associations with mortality
Katharina C. Kiefer et al.
ESC HEART FAILURE (2021)
The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene Ppm1d Promotes Inflammation and Non-Ischemic Heart Failure in Mice
Yoshimitsu Yura et al.
CIRCULATION RESEARCH (2021)
Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure
Bing Yu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Somatic Mutations in Benign Disease
Satu Mustjoki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The evolution of hematopoietic cells under cancer therapy
Oriol Pich et al.
NATURE COMMUNICATIONS (2021)
Clonal expansion in non-cancer tissues
Nobuyuki Kakiuchi et al.
NATURE REVIEWS CANCER (2021)
Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation
Silvia Mas-Peiro et al.
EUROPEAN HEART JOURNAL (2020)
Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease
Siddhartha Jaiswal et al.
NATURE REVIEWS CARDIOLOGY (2020)
Genetic Interleukin 6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal Hematopoiesis
Alexander G. Bick et al.
CIRCULATION (2020)
Clonal hematopoiesis driven by somatic mutations: A new player in atherosclerotic cardiovascular disease
Marta Amoros-Perez et al.
ATHEROSCLEROSIS (2020)
The Clinical Management of Clonal Hematopoiesis Creation of a Clonal Hematopoiesis Clinic
Kelly L. Bolton et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2020)
Inflammation in Heart Failure JACC State-of-the-Art Review
Sean P. Murphy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk Factor
Robert Sidlow et al.
JAMA CARDIOLOGY (2020)
Clonal hematopoietic mutations linked to platelet traits and the risk of thrombosis or bleeding
Alicia Veninga et al.
HAEMATOLOGICA (2020)
Inherited causes of clonal haematopoiesis in 97,691 whole genomes
Alexander G. Bick et al.
NATURE (2020)
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
Kelly L. Bolton et al.
NATURE GENETICS (2020)
TET2-Loss-of-Function-Driven Clonal Hematopoiesis Exacerbates Experimental Insulin Resistance in Aging and Obesity
Jose J. Fuster et al.
CELL REPORTS (2020)
Tet2-mediated clonal hematopoiesis in nonconditioned mice accelerates age-associated cardiac dysfunction
Ying Wang et al.
JCI INSIGHT (2020)
Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation
Silvia Mas-Peiro et al.
EUROPEAN HEART JOURNAL (2020)
Cardiac and genetic predictors of cardiovascular risk in patients with myelodysplastic syndromes
Evan C. Chen et al.
LEUKEMIA & LYMPHOMA (2019)
Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population
Sabrina Cordua et al.
BLOOD (2019)
Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD JACC Review Topic of the Week
Sumeet A. Khetarpal et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
A population-based study of cardiovascular diseasemortality risk in US cancer patients
Kathleen M. Sturgeon et al.
EUROPEAN HEART JOURNAL (2019)
Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic lschemic Heart Failure
Lena Dorsheimer et al.
JAMA CARDIOLOGY (2019)
JAK2V617F-Mediated Clonal Hematopoiesis Accelerates Pathological Remodeling in Murine Heart Failure
Soichi Sano et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2019)
PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells
Josephine D. Kahn et al.
BLOOD (2018)
Somatic Mutations and Clonal Hematopoiesis: Unexpected Potential New Drivers of Age-Related Cardiovascular Disease
Jose J. Fuster et al.
CIRCULATION RESEARCH (2018)
Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome
Soichi Sano et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms
Ofir Wolach et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential
Terrence N. Wong et al.
NATURE COMMUNICATIONS (2018)
Primary Cancer vs Competing Causes of Death in Survivors of Head and Neck Cancer
Matthew C. Simpson et al.
JAMA ONCOLOGY (2018)
Population dynamics of normal human blood inferred from somatic mutations
Henry Lee-Six et al.
NATURE (2018)
PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy
Joanne Hsu et al.
CELL STEM CELL (2018)
Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2(V617F) Mice
Wei Wang et al.
CIRCULATION RESEARCH (2018)
Somatic Mutations Reveal Lineage Relationships and Age-Related Mutagenesis in Human Hematopoiesis
Fernando G. Osorio et al.
CELL REPORTS (2018)
Causes of death among cancer patients
N. G. Zaorsky et al.
ANNALS OF ONCOLOGY (2017)
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
S. Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
Jose J. Fuster et al.
SCIENCE (2017)
Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy
Xinqiang Han et al.
NPJ PRECISION ONCOLOGY (2017)
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes
Catherine C. Coombs et al.
CELL STEM CELL (2017)
Myeloid p53 regulates macrophage polarization and venous thrombus resolution by inflammatory vascular remodeling in mice
Subhradip Mukhopadhyay et al.
BLOOD (2017)
Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease
Jose J. Fuster et al.
CIRCULATION RESEARCH (2016)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
Jose Luis Zamorano et al.
EUROPEAN HEART JOURNAL (2016)
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
David P. Steensma et al.
BLOOD (2015)
Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6
Qian Zhang et al.
NATURE (2015)
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
Terrence N. Wong et al.
NATURE (2015)
Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm
Lamia Lamrani et al.
BLOOD (2014)
Conditional survival for long-term colorectal cancer survivors in the Netherlands: who do best?
F. N. van Erning et al.
EUROPEAN JOURNAL OF CANCER (2014)
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Mingchao Xie et al.
NATURE MEDICINE (2014)
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
JAK2V617F leads to intrinsic changes in platelet formation and reactivity in a knock-in mouse model of essential thrombocythemia
Catherine M. Hobbs et al.
BLOOD (2013)
The Origin and Evolution of Mutations in Acute Myeloid Leukemia
John S. Welch et al.
CELL (2012)
Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis
Lambert Busque et al.
NATURE GENETICS (2012)
Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies
Zhe Li et al.
BLOOD (2011)
TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis
Cyril Quivoron et al.
CANCER CELL (2011)
Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation
Kelly Moran-Crusio et al.
CANCER CELL (2011)
Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice
Myunggon Ko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study
Jennifer L. Patnaik et al.
BREAST CANCER RESEARCH (2011)
Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice
Caroline Marty et al.
BLOOD (2010)
Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease
Hajime Akada et al.
BLOOD (2010)
JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia
Juan Li et al.
BLOOD (2010)
p53-Mediated Hematopoietic Stem and Progenitor Cell Competition
Tanya Bondar et al.
CELL STEM CELL (2010)
Irradiation Selects for p53-Deficient Hematopoietic Progenitors
Andriy Marusyk et al.
PLOS BIOLOGY (2010)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)